Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
February 24 2021 - 4:58PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 6-K
Report of Foreign
Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities
Exchange Act of 1934
For the Month of
February, 2021
Commission File
Number: 001-37353
BIONDVAX PHARMACEUTICALS
LTD.
(Translation of
registrant’s name into English)
Jerusalem BioPark,
2nd Floor
Hadassah Ein
Kerem Campus
Jerusalem, Israel
(Address of principal
executive office)
Indicate by check
mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
BiondVax Pharmaceuticals
Ltd. (hereinafter, the “Company”) announces that it is rescheduling its Extraordinary Meeting of Shareholders originally
scheduled for March 31, 2021 to April 6, 2021 at 4:00 p.m. Israel time at the offices of the Gross & Co., One Azrieli Center,
Tel Aviv 6701101, Israel.
The Company hereby
furnishes as Exhibit 99.1 to this Form 6-K a Notice with respect to the Company’s Extraordinary
Meeting of Shareholders .
Exhibit
Index
Exhibit 99.1 is
hereby incorporated by reference into the Company's Registration Statement on Form F-3 (Registration No. 333-240189) and
its Registration Statement on Form S-8 (Registration No. 333-239344).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
BiondVax Pharmaceuticals
Ltd.
|
|
|
|
Date: February 24, 2021
|
By:
|
/s/
Amir Reichman
|
|
|
Amir Reichman
|
|
|
Chairman of the Board
|
BiondVax Pharmaceuticals (NASDAQ:BVXV)
Historical Stock Chart
From Aug 2024 to Sep 2024
BiondVax Pharmaceuticals (NASDAQ:BVXV)
Historical Stock Chart
From Sep 2023 to Sep 2024